Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Short term Debt (2017)

Dexcom (DXCM) has disclosed Short term Debt for 8 consecutive years, with $75.0 million as the latest value for Q1 2017.

  • On a quarterly basis, Short term Debt rose 4311.76% to $75.0 million in Q1 2017 year-over-year; TTM through Mar 2017 was $75.0 million, a 4311.76% increase, with the full-year FY2015 number at $2.3 million, changed 0.0% from a year prior.
  • Short term Debt was $75.0 million for Q1 2017 at Dexcom, up from $1.7 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $75.0 million in Q1 2017 to a low of $700000.0 in Q1 2013.
  • A 5-year average of $7.2 million and a median of $2.3 million in 2014 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: decreased 29.17% in 2016, then surged 4311.76% in 2017.
  • Dexcom's Short term Debt stood at $2.2 million in 2013, then increased by 4.55% to $2.3 million in 2014, then changed by 0.0% to $2.3 million in 2015, then dropped by 26.09% to $1.7 million in 2016, then soared by 4311.76% to $75.0 million in 2017.
  • Per Business Quant, the three most recent readings for DXCM's Short term Debt are $75.0 million (Q1 2017), $1.7 million (Q1 2016), and $2.3 million (Q4 2015).